Ligand validation:6AWN

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6AWN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AWN_NAG_A_701	73%	77%	0.078	0.903	0.27	0.64	-	-	0	0	100%	0.9333
6AWN_NAG_A_704	8%	13%	0.156	0.631	1.94	2.05	2	2	0	0	100%	0.9333
5I74_NAG_A_701	87%	84%	0.064	0.935	0.23	0.52	-	-	2	0	100%	0.9333
5I71_NAG_A_702	78%	83%	0.085	0.928	0.21	0.57	-	-	1	0	100%	0.9333
5I75_NAG_A_702	66%	85%	0.085	0.888	0.29	0.44	-	-	0	0	100%	0.9333
5I6X_NAG_A_701	65%	77%	0.098	0.899	0.27	0.63	-	-	1	0	100%	0.9333
6AWQ_NAG_A_702	55%	83%	0.197	0.967	0.24	0.53	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.